Suchergebnisse - "Arnold, D"

PubPharm (2.078)

1

Risk and mitigation of aerosolisation from lung function testing: results from the AERATOR study

enthalten in: bioRxiv.org | 2024

von Sheikh, S. | Hamilton, F. | Nava, G. | +8

2

Monopolar diathermy versus a vessel-sealing device for reducing postoperative drain output after simple mastectomy : randomized clinical trial

enthalten in: The British journal of surgery | 2024

von Keelan, S. | Dowling, G. | Roche, T. | +12

3

PARP Inhibitors in Breast Cancer : a Short Communication

enthalten in: Current oncology reports | 2024

von Daly, G. | AlRawashdeh, M. | McGrath, J. | +6

4

Inflammatory fibroid polyp of the small intestine presenting as small bowel obstruction with intussusception : a case report

enthalten in: Journal of surgical case reports | 2024

von Hehir, C. | Calpin, G. | Dowling, G. | +3

5

Neoadjuvant trastuzumab deruxtecan (T-DXd) with response-directed definitive therapy in early stage HER2-positive breast cancer : a phase II study protocol (SHAMROCK study)

enthalten in: BMC cancer | 2024

von Dowling, G. | Toomey, S. | Bredin, P. | +12

6

Neoadjuvant trastuzumab deruxtecan (T-DXd) with response-directed definitive therapy in early stage HER2-positive breast cancer: a phase II study protocol (SHAMROCK study)

enthalten in: BMC cancer | 2024

von Dowling, G. | Toomey, S. | Bredin, P. | +12

7

Accelarated immune ageing is associated with COVID-19 disease severity

enthalten in: Immunity & ageing : I & A | 2024

von Lord, J. | Veenith, T. | Sullivan, J. | +121

8

Nodal positivity in patients with clinically and radiologically node-negative breast cancer treated with neoadjuvant chemotherapy : multicentre collaborative study

enthalten in: The British journal of surgery | 2024

von Zaborowski, A. | Doogan, K. | Clifford, S. | +23

9

PARP Inhibitors in Breast Cancer: a Short Communication

enthalten in: Current oncology reports | 2024

von Daly, G. | AlRawashdeh, M. | McGrath, J. | +6

10

Neoadjuvant trastuzumab deruxtecan (T-DXd) with response-directed definitive therapy in early stage HER2-positive breast cancer: a phase II study protocol (SHAMROCK study)

in: BMC Cancer | 2024

von Gavin P. Dowling | Sinead Toomey | Philip Bredin | +12

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[208]